Table 1.
Patients characteristics
| Upon admission | Upon Discharge | |||||
|---|---|---|---|---|---|---|
| Characteristic H1N1(+) | Mean | Range | (±SD) | Mean | Range | (±SD) |
| Age (years) | 36 | 14-65 | (14.7) | |||
| Male/Female (n, %) | 28/16 (63.6%/36.3%) | |||||
| Smokers | ||||||
| (male/female) (n, %) | 8/28 (28.6%) and 3/16 (18.8%) | |||||
| Non-Smokers | ||||||
| (male/female) | 20/28 (71.4%) and 13/16 (81.3%) | |||||
| BMI | 30.23 | 20-45 | (8.757) | |||
| No,pts with obesity (male/female) | 7/28 (25%) and 4/16 (25%) | |||||
| No.pts without obesity (male/female) | 21/28 (75%) and 12/16 (75%) | |||||
| Co-exististing conditions (n, %) | ||||||
| Asthma | 15/44 (34%) | |||||
| COPD | 6/44 (13.6%) | |||||
| IPF | 1/44 (2.2%) | |||||
| Lymphoma | 5/44 (11.3%) | |||||
| Diabetes | 8/44 (18.1%) | |||||
| Coronary Heart Disease | 10/44 (22.7%) | |||||
| Outcomes-days | ||||||
| Duration of fever in hospital under treatment | 2.45 | 1-4 | (0.875) | |||
| Days of Hospitalization | 5.39 | 3-12 | (1.781) | |||
| Days under oseltamivir regimen | 5.25 | 4-10 | (1.014) | |||
| Adverse events (n, %) | ||||||
| Abnormal liver function | 7/44 (15.9%) | |||||
| Nausea, Diarrhea | 4.5% | |||||
| Vomiting | 1.4% | |||||
| Hypoxemia | 1/44 (21.2%) | |||||
| CRP | 5.18 | 0.26-17.38 | (5.123) | 1.33 | 0.16-4.53 | (1.01) |
| WBC | 7.114 | 3.340-10.950 | (2172.160) | 6.806 | 3340-10950 | (2021.6) |
| Fever | 39.06 | 37-40 | (0.834) | 37.8 | 36.3-39.2 | (0.77) |
| CR | 0.9 | 0.5-1.30 | (0.17) | 0.8 | 5-1 | (0.12) |
| UR | 26.18 | 11-41 | (7.469) | 25.11 | 12-40 | (7.127) |
| SGPT | 24.48 | 10-138 | (26.37) | 27.80 | 9-136 | (26.719) |
| SGOT | 27.09 | 14-125 | (22.941) | 24.14 | 9-57 | (12.22) |
| Spo2 (FiO2 21%) | 96.07 | 89-99 | (2.3) | 96.98 | 94-99 | (1.248) |
| PO2 (FiO221%) | 81.23 | 53-113 | (14.586) | 87.66 | 67-113 | (12.473) |
| Abnormalities on chest radiograph (n, %) | ||||||
| Local patchy shadowing | 8/44 (18.1%) | 6/44 (13.6%) | ||||
| Ground-glass opacities | 3/44 (6.8%) | 2/44 (4.5%) | ||||
| Interstitial abnormality | 1/44 (2.2%) | 1/44 (2.2%) | ||||